All In MedTech

Device Trial Radar · NCT00582946

Wide-Bandwidth Open Canal Hearing Aid For Better Multitalker Speech Understanding

Last checked: Nov 20, 2026Latest source record: Nov 4, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

16

Actual

Start

May 2006

Primary completion

Dec 2009

Study completion Dec 2009

Sponsor

Lead sponsor
EarLens CorporationNot on our public-company list
Sponsor type
Industry
Collaborators
National Institute on Deafness and Other Communication Disorders (NIDCD)
First posted
Dec 28, 2007

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Basic science
Who can join
All sexes, from 21 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Our goal is to design and build a new hearing aid system, which mitigates the most common complaints that hearing aid users have. These include hearing in multi-talker situations, poor sound quality, unwanted whistling resulting from feedback, and a dislike of the sound of their own voice. Current efforts, with limited success, use signal processing methods rather than restoring more closely the normal auditory function. We plan to achieve our goal by reducing to practice three key enabling concepts. The first is to replace the current acoustic transducer with a non-acoustic mechanical output transducer that directly actuates the tympanic membrane (TM). This transducer, called the EarLens, floats on the tympanic membrane in a manner similar to the way a contract lens floats on the eye. The second is to increase the output bandwidth of the hearing aid. The third key concept is to place a wide-bandwidth microphone in the ear canal to capture the pinna diffraction cues similarly to the way the normal ear functions. Our central hypothesis is that a hearing aid that delivers amplified wide-bandwidth mechanical stimuli, directionally dependent cues, in an open canal configuration will perform better than conventional hearing aids when there are competing talkers in the background. First phase includes verification the capability of the system to deliver sufficient maximum equivalent pressure output (MEPO) to treat the degree of hearing loss in the target fitting range.

Conditions

  • Hearing Impairment

Interventions

  • Hearing AidDevice

    Subjects were treated with a hearing aid which provided amplification intended to treat mild to moderate sensorineural hearing loss.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Maximum Effective Sound Pressure Level (MEPO)Time frame: 1 month

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Ear Lens Corporation

    Redwood City, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.